menu
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, Roots Analysis.
Advances inbiotechnology have enabled the identification of several novel biomarkers,which are presently being used for a variety of purposes

Report Keywords –  Cancer Biomarkers, Biomarkers Market, biomarkers, RootsAnalysis

 

Advances inbiotechnology have enabled the identification of several novel biomarkers,which are presently being used for a variety of purposes, including diagnosis,drug development, clinical research and to facilitate therapy-relateddecisions.

 

RootsAnalysis is pleased to announce thepublication of its recent study, titled, “Cancer Biomarkers Market:Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.

 

The report features an extensive study of the current landscape andfuture outlook of the immuno-oncology biomarkers testing market (focusingparticularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides anin-depth analysis, highlighting the capabilities of the various companiesengaged in this domain. Amongst various elements, the report includes:

§ A detailed analysis of ongoing, biomarker-based clinical trialsinitiated by big pharmaceutical companies. 

§ An analysis of the landscape of companies offering testing servicesfor cancer biomarkers, namely TMB, MSI / MMR and TILs (including CD3+, CD4+,CD8+ and FOXP3+).

§ An insightful 2X2 representation of the results of a detailedcompetitiveness analysis of various tests (segregatedacross different biomarker groups).

§ Elaborate profiles of leading analytical testing service providersfocused on immuno-oncology biomarkers (shortlistedbased on strength of service portfolio).

§ A detailed publication analysis of over 180 research articles thathave been published since 2016, highlighting the key focus areas of ongoingresearch activity related to immuno-oncology biomarkers, namely TMB, MSI / MMRand TILs.

§ A comprehensive clinical trial analysis of completed, ongoing andplanned studies, focused on the assessment of cancer biomarkers, namely TMB,MSI / MMR and TILs.

§ A discussion on the upcoming opportunities that are likely toimpact the evolution of this market over the coming years.

§ A discussion on various steps involved in development operations ofcompanion diagnostics

§ A comparative analysis of the needs of different stakeholdersinvolved in the development of companion diagnostic products

§ A detailed market forecast,featuring analysis of the current and projected future opportunity across keymarket segments (listed below)

 

To request asample report – https://www.rootsanalysis.com/reports/253/request-sample.html

 

  • Type of test

§ Laboratory Developed Tests (LDTs)

§ Companion Diagnostic Tests (CDx)

  • Type of disease indication

§ Breast cancer

§ Blood cancer

§ Colon / Colorectal cancer

§ Lung Cancer

§ Melanoma

§ Prostate Cancer

  • Type of cancer biomarker

§ TMB

§ MSI / MMR

§ TILs

  • Type of analytical technique

§ Next Generation Sequencing (NGS)

§ Polymerase Chain Reaction (PCR)

§ Immunohistochemistry (IHC)

§ Others

 

  • Key geographical regions

§ North America

§ Europe

§ Japan

§ China

§ Australia 

 

Torequest a Customize report -  https://www.rootsanalysis.com/reports/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--/request-customization.html

 

Keycompanies covered in the report

§  FoundationMedicine

§  NeoGenomicsLaboratories

§  Novogene

§  Q2Solutions

§  PersonalGenome Diagnostics

§  Dr LalPathLabs

§  ShenzhenYuce Biotechnology

 

For moreinformation please click on the following link:

https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html

 

Other RecentOfferings

1.     GlobalT-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030

2.     NeoantigenTargeted Therapies Market, 2019-2030

3.     CompanionDiagnostics Market (2nd Edition), 2019-2030

4.     CellEncapsulation:Focus on Therapeutics and Technologies, 2019-2030

5.     InVitro ADME Testing Services Market, 2019-2030

6.    HPAPI and Cytotoxic Drugs ManufacturingMarket (3rd Edition), 2020-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis